Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (171-180 of 222) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|July 24, 2012
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical courseSven Perner, Niels J Rupp, Martin Braun, et al.
Clinical Chemistry|December 6, 2012
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancerCarsten Stephan, Klaus Jung, Axel Semjonow, et al.
International Journal of Molecular Sciences|October 27, 2020
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological FactorsHannah Rochow, Monika Jung, Sabine Weickmann, et al.
Clinical Genitourinary Cancer|November 19, 2018
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell CarcinomaTim Müller, Yuri Tolkach, David Stahl, et al.
The Prostate|January 3, 2006
Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural networkCarsten Stephan, Chuanliang Xu, David A Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortRaquel Esgueva, Sven Perner, Christopher J LaFargue, et al.
European Radiology|December 15, 2017
A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressivenessAlexander D J Baur, Julia Schwabe, Julian Rogasch, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 8, 2005
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?Falk Ohl, Monika Jung, Chuanliang Xu, et al.
Oncogene|April 18, 2002
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat modelMichael Lein, Klaus Jung, Bernhard Ortel, et al.
Pageof 23

Showing results (171-180 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|July 24, 2012
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical courseSven Perner, Niels J Rupp, Martin Braun, et al.
Clinical Chemistry|December 6, 2012
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancerCarsten Stephan, Klaus Jung, Axel Semjonow, et al.
International Journal of Molecular Sciences|October 27, 2020
Circular RNAs and Their Linear Transcripts as Diagnostic and Prognostic Tissue Biomarkers in Prostate Cancer after Prostatectomy in Combination with Clinicopathological FactorsHannah Rochow, Monika Jung, Sabine Weickmann, et al.
Clinical Genitourinary Cancer|November 19, 2018
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell CarcinomaTim Müller, Yuri Tolkach, David Stahl, et al.
The Prostate|January 3, 2006
Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural networkCarsten Stephan, Chuanliang Xu, David A Brown, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2010
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortRaquel Esgueva, Sven Perner, Christopher J LaFargue, et al.
European Radiology|December 15, 2017
A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressivenessAlexander D J Baur, Julia Schwabe, Julian Rogasch, et al.
The Journal of Urology|November 11, 2005
A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigenMichael Lein, Axel Semjonow, Markus Graefen, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 8, 2005
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?Falk Ohl, Monika Jung, Chuanliang Xu, et al.
Oncogene|April 18, 2002
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat modelMichael Lein, Klaus Jung, Bernhard Ortel, et al.
Pageof 23